Back to Search
Start Over
Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data.
- Source :
-
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology [EuroIntervention] 2015 Nov; Vol. 11 (7), pp. 746-56. - Publication Year :
- 2015
-
Abstract
- Aims: To evaluate the implications of an Absorb bioresorbable vascular scaffold (Absorb BVS) on the morphology of the superficial plaques.<br />Methods and Results: Forty-six patients who underwent Absorb BVS implantation and 20 patients implanted with bare metal stents (BMS) who had serial optical coherence tomographic examination at baseline and follow-up were included in this analysis. The thin-capped fibroatheromas (TCFA) were identified in the device implantation regions and in the adjacent native coronary segments. Within all regions, circumferential locations of TCFA and calcific tissues were identified, and the neointimal thickness was measured at follow-up. At six to 12-month follow-up, only 8% of the TCFA detected at baseline were still present in the Absorb BVS and 27% in the BMS implantation segment (p=0.231). Sixty percent of the TCFA in native segments did not change their phenotype at follow-up. At short-term follow-up, significant reduction in the lumen area of the BMS was noted, which was higher compared to that reported in the Absorb BVS group (-2.11±1.97 mm2 vs. -1.34±0.99 mm2, p=0.026). In Absorb BVS, neointima tissue continued to develop at midterm follow-up (2.17±0.48 mm2 vs. 1.38±0.52 mm2, p<0.0001) and covered the underlying tissues without compromising the luminal dimensions (5.93±1.49 mm2 vs. 6.14±1.49 mm2, p=0.571) as it was accommodated by the expanded scaffold (8.28±1.74 mm2 vs. 7.67±1.28 mm2, p<0.0001).<br />Conclusions: Neointimal tissue develops following either Absorb BVS or BMS implantation and shields lipid tissues. The neointimal response in the BMS causes a higher reduction of luminal dimensions compared to the Absorb BVS. Thus, Absorb BVS may have a value in the invasive re-capping of high-risk plaques.
- Subjects :
- Aged
Clinical Trials as Topic
Coronary Angiography
Coronary Artery Disease diagnostic imaging
Coronary Artery Disease pathology
Coronary Vessels diagnostic imaging
Female
Fibrosis
Follow-Up Studies
Humans
Male
Metals
Middle Aged
Percutaneous Coronary Intervention adverse effects
Phenotype
Predictive Value of Tests
Prosthesis Design
Stents
Time Factors
Treatment Outcome
Absorbable Implants
Coronary Artery Disease therapy
Coronary Vessels pathology
Neointima
Percutaneous Coronary Intervention instrumentation
Plaque, Atherosclerotic
Tomography, Optical Coherence
Subjects
Details
- Language :
- English
- ISSN :
- 1969-6213
- Volume :
- 11
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
- Publication Type :
- Academic Journal
- Accession number :
- 25308301
- Full Text :
- https://doi.org/10.4244/EIJY14M10_06